Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6-Month Safety and Efficacy Results of Two Randomized Studies-Reference-Cited by-同舟云学术

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6-Month Safety and Efficacy Results of Two Randomized Studies

Published:2004-04 Issue:4 Volume:4 Page:626-635
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Vitko Stefan,Tedesco Helio,Eris Josette,Pascual Julio,Whelchel John,Magee John C.,Campbell Scott,Civati Giovanni,Bourbigot Bernard,Filho Gentil Alves,Leone John,Garcia Valter Duro,Rigotti Paolo,Esmeraldo Ronaldo,Cambi Vincenzo,Haas Tomas,Jappe Annette,Bernhardt Peter,Geissler Johanna,Cretin Nathalie

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2004.00389.x/fullpdf

Reference35 articles.

1. Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996

2. Post-transplant renal function in the first year predicts long-term kidney transplant survival

3. PRECLINICAL EVALUATION OF A NEW POTENT IMMUNOSUPPRESSIVE AGENT, RAPAMYCIN

4. Early Clinical Experience With a Novel Rapamycin Derivative

5. Rapamune (Sirolimus, Rapamycin): An Overview and Mechanism of Action

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

2. Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients;Journal of Clinical Medicine;2024-07-23

3. Special Patient Populations;Clinical Lipidology;2024

4. Everolimus plus reduced calcineurin inhibitor prevents de novo anti-HLA antibodies and humoral rejection in kidney transplant recipients: 12-month results from the ATHENA study;Frontiers in Transplantation;2023-10-27

5. Pharmacokinetics of immunosuppressive agents during hemoperfusion in a sheep model;Frontiers in Medicine;2023-10-20